Cargando…
Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson’s Disease
Parkinson’s disease (PD) is the second most common neurodegenerative disease, affecting the elderly worldwide and causing significant movement impairments. The goal of PD treatment is to restore dopamine levels in the striatum and regulate movement symptoms. The lack of specific biomarkers for early...
Autores principales: | Tryphena, Kamatham Pushpa, Anuradha, Urati, Kumar, Rohith, Rajan, Shruti, Srivastava, Saurabh, Singh, Shashi Bala, Khatri, Dharmendra Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473154/ https://www.ncbi.nlm.nih.gov/pubmed/35848027 http://dx.doi.org/10.3233/JAD-220449 |
Ejemplares similares
-
Microtubule acetylation dyshomeostasis in Parkinson’s disease
por: Naren, Padmashri, et al.
Publicado: (2023) -
CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease
por: Pinjala, Poojitha, et al.
Publicado: (2023) -
Epigenetics in depression and gut-brain axis: A molecular crosstalk
por: Begum, Nusrat, et al.
Publicado: (2022) -
Pathological and Therapeutic Advances in Parkinson’s Disease: Mitochondria in the Interplay
por: Naren, Padmashri, et al.
Publicado: (2023) -
CRISPR/Cas9 Genome Editing for Tissue‐Specific In Vivo Targeting: Nanomaterials and Translational Perspective
por: Sahel, Deepak Kumar, et al.
Publicado: (2023)